Recurrent second trimester pregnancy loss: Evaluation and management

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 16, Issue 6, 2009, Pages 451-458

  Dukhovny, Stephanie ^a   Zutshi, Priyanka ^a   Abbott, Jodi F ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical insufficiency; Fetal demise; Miscarriage; Recurrent second trimester pregnancy loss; Thrombophilia

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; HEMOGLOBIN A1C; HYDROXYPROGESTERONE;

ANTIPHOSPHOLIPID SYNDROME; BLEEDING; CERCLAGE; CERVICAL SPINE INJURY; CHORIOAMNIONITIS; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL TRIAL; DIABETES MELLITUS; ECHOGRAPHY; EVIDENCE BASED MEDICINE; GESTATIONAL AGE; HUMAN; HYPERTENSION; HYPERTHYROIDISM; HYPOTHYROIDISM; HYSTEROSALPINGOGRAPHY; HYSTEROSCOPY; HYSTEROTOMY; INTRAUTERINE CONTRACEPTIVE DEVICE; MYOMECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PLACENTA; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; RECURRENT DISEASE; REVIEW; SECOND TRIMESTER PREGNANCY; THROMBOPHILIA; ULTRASOUND; UTERINE CERVIX DILATATION; UTERINE CERVIX INCOMPETENCE; UTERUS DISEASE; UTERUS MYOMA;

ABORTION, HABITUAL; FEMALE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, SECOND;

EID: 70350757702     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e328332b808     Document Type: Review

References (60)

1. Simpson J. Causes of fetal wastage. Clin Obstet Gynecol 2007; 50:10-30.
2. Wu S, Stephenson MD. Obstetrical antiphospholipid syndrome. Semin Reprod Med 2006; 24:40-53.
3. ACOG practice bulletin. Antiphospholipid Syndrome. Number 68, November 2005. The American College of Obstetricians and Gynecologists. Obstet Gynecol 2005; 106:1113-1121.
4. Kutteh WH, Franklin RD. Assessing the variation in antiphospholipid antibody (APA) assays: Comparison of results from 10 centers. Am J Obstet Gynecol 2004; 91:440-448.
5. Silver RM, Pierangeli SS, Edwin SS, et al. Pathogenic antibodies in women with obstetric features of antiphospholipid syndrome who have negative test results for lupus anticoagulant and anticardiolipin antibodies. Am J Obstet Gynecol 1997; 176:628-633.
6. Kutteh WH, Triplett DA. Thrombophilias and recurrent pregnancy loss. Semin Reprod Med 2006; 24:54-65.
7. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: A meta-analysis. Lancet 2003; 361:901-908.
8. Benhadi N, Wiersinga WM, Reitsma JB, et al. Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur J Endocrinol 2009; 160:985-991.
9. Abramson J, Stagnaro-Green A. Thyroid antibodies and fetal loss: An evolving story. Thyroid 2001; 11:57-63.
10. Negro R, Formoso G, Mangieri T, et al. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: Effects on obstetrical complications. J Clin Endocrinol Metab 2006; 91:2587-2591.
11. Chang AY, Chamberlain-Shea H, Carr B. Fetal loss associated with excess thyroid hormone exposure. J Am Med Assoc 2005; 293:160-161.
12. Lazarus JH. Thyroid disorders associated with pregnancy: Etiology, diagnosis, and management. Treat Endocrinol 2005; 4:31-41.
13. Stagnaro-Green A, Roman S, Cobin R, et al. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. J Am Med Assoc 1990; 264:1422-1425.
14. DeFranco E, Teramo K, Muglia L. Genetic influences on preterm birth. Semin Reprod Med 2007; 25:40-51.
15. Wilcox AJ, Skjærven R, Lie RT. Familial patterns of preterm delivery: maternal and fetal contributions. Am J Epidemiol 2008; 167:474-479.
16. Pennell CE, Jacobsson B, Williams SM, et al. Genetic epidemiologic studies of preterm birth: Guidelines for research. Am J Obstet Gynecol 2007; 196:107-118.
17. Hobel C, Culhane J. Role of psychosocial and nutritional stress on poor pregnancy outcome. J Nutr 2003; 133 (5 Suppl 2):1709S-1717S.
18. Lockwood CJ. Stress-associated preterm delivery: The role of corticotrophinreleasing hormone. Am J Obstet Gynecol 1999; 180 (1 Suppl 2):S264-S266.
19. Brett KM, Strogatz DS, Savitz DA. Employment, job strain, and preterm delivery among women in North Carolina. Am J Public Health 1997; 87:199-204.
20. Wadhwa PD, Culhane JF, Rauh V, Barve SS. Stress and preterm birth: neuroendocrine, immune/inflammatory, and vascular mechanisms. Matern Child Health J 2001; 5:119-125.
21. Kelly S, Pollock M, Maas B, et al. Early transvaginal ultrasonography versus early cerclage in women with an unclear history of incompetent cervix. Am J Obstet Gynecol 2001; 84:1097-1099.
22. Empson M, Lassere M, Craig JC, Scott JR. Recurrent pregnancy loss with antiphospholipid antibody: A systematic review of therapeutic trials. Obstet Gynecol 2002; 99:135-144. (Pubitemid 34075480)
23. Salafia CM, Cowchock FS. Placental pathology and antiphospholipid antibodies: A descriptive study. Am J Perinat 1997; 14:435-441.
24. Van Horn JT, Craven K, Ward DW, Branch W. Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes. Placenta 2004; 25:642-648.
25. Rust OA, Atlas RO, Jones KJ, et al. A randomized trial of cerclage versus no cerclage among patients with ultrasonographically detected second-trimester preterm dilatation of the internal os. Transactions of the twentieth annual meeting of the Society for Maternal-Fetal Medicine. Am J Obstet Gynecol 2000; 183:830-835.
26. Wold ASD, Pham N, Arici A. Anatomic factors in recurrent pregnancy loss. Semin Reprod Med 2006; 24:25-32.
27. Homer HA, Li TC, Cooke ID. The septate uterus: A review of management and reproductive outcome. Fertil Steril 2000; 73:1-14.
28. Pellerito JS, McCarthy SM, Doyle MB, et al. Diagnosis of uterine anomalies: Relative accuracy of MR imaging, endovaginal sonography, and hysterosalpingography. Radiology 1992; 183:795-800.
29. Reuter KL, Daly DC, Cohen SM. Septate versus bicornuate uteri: Errors in imaging diagnosis. Radiology 1989; 172:749-752.
30. Benson CB, Chow JS, Chang-Lee W, et al. Outcome of pregnancies in women with uterine leiomyomas identified by sonography in the first trimester. J Clin Ultrasound 2001; 29:261-264.
31. Jurkovic D, Geipel A, Gruboeck K, et al. Three-dimensional ultrasound for the assessment of uterine anatomy and detection of congenital anomalies: A comparison with hysterosalpingography and two-dimensional sonography. Ultrasound Obstet Gynecol 1995; 5:233-237.
32. Lev-Toaff AS, Pinheiro LW, Bega G, et al. Three-dimensional multiplanar sonohysterography: Comparison with conventional two-dimensional sonohysterography and X-ray hysterosalpingography. J Ultrasound Med 2001; 20:295-306.
33. Fischetti SG, Politi G, Lomeo E, Garozzo G. Magnetic resonance in the evaluation of Mullerian duct anomalies. Radiol Med 1995; 89 (1-2):105-111.
34. Shirodkar VN. A new method of operative treatment for habitual abortions in the second trimester of pregnancy. Antiseptic 1955; 52:299-300.
35. McDonald IA. Suture of the cervix for inevitable miscarriage. J Obstet Gynaecol Br Empire 1957; 64:346-350.
36. Cervical insufficiency. ACOG Practice Bulletin No. 48. The American College of Obstetricians and Gynecologists. Obstet Gynecol 2003; 102:1091-1099.
37. Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists mulicentre randomized trial of cervical cerclage. MRC/ RCOG Working Party on cervical cerclage. Br JObstetGynaecol 1993; 100: 516-523.
38. Burghella V, Odibo AO, To MS, et al. Cerclage for short cervix on ultrasonography. Obstet Gynecol 2005; 106:181-189.
39. Burghella V, Seibel-Seamon J. Contemporary use of cervical cerclage. Clin Obstet Gynecol 2007; 50:468-477.
40. Bakketeig LS, Hortman H, Harely EE. The tendency to repeat gestational age and birthweight in successive births. Am J Obstet Gencol 1979; 135:1086-1103.
41. Li TC, Mortimer R, Cooke ID. Myomectomy: A retrospective study to examine reproductive performance before and after surgery. Hum Reprod 1999; 14:1735-1740.
42. Raga F, Bauset C, Remohi J, et al. Reproductive impact of congenital Mullerian anomalies. Hum Reprod 1997; 12:2277-2291.
43. Propst AM, Hill JA. Anatomical factors associated with recurrent pregnancy loss. Semin Reprod Med 2000; 18:341-350.
44. Wajntraub G, Milwidsky A, Weiss D. Prevention of premature delivery in a unicornuate uterus by cervical cerclage. Acta Obstet Gynecol Scand 1975; 54:497-498.
45. Heinonen PK, Saarikoski S, Pystynen P. Reproductive performance of women with uterine anomalies: An evaluation of 182 cases. Acta Obstet Gynecol Scand 1982; 61:157-162.
46. Taylor E, Gomel V. The uterus and fertility. Fertil Steril 2008; 89:1-16.
47. Shenker J, Margalioth EJ. Intrauterine adhesions: An updated appraisal. Fertil Steril 1982; 37:593-610.
48. Fernandez H, Al-Najjar F, Chauveaud-Lambling A, et al. Fertility after treatment of Asherman's syndrome stage 3 and 4. J Minim Invasive Gynecol 2006; 13:398-402.
49. Edlow AG, Srinivas S, Elovitz MA. Second trimester loss and subsequent pregnancy outcomes: what is the real risk? Am J Obstet Genecol 2007; 197:581.e1-581.e6.
50. Srinivas SK, Ernst LM, Edlow AG, et al. Can placental pathology explain second-trimester pregnancy loss and subsequent pregnancy outcomes? Am J Obstet Gynecol 2008; 199:402.e1-402.e5.
51. Brenner B. Thrombophilia and pregnancy loss. Thromb Res 2003; 108:197-202.
52. Meis PJ, Klebanoff M, Thom E, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348:2379-2385.
53. da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomized placebocontrolled double-blind study. Am J Obstet Gynecol 2003; 188:419-424.
54. Spong C, Meis P, Thom E, et al. Progesterone for prevention of recurrent preterm birth: Impact of gestational age at previous delivery. Am J Obstet Gynecol 2005; 193:1127-1131.
55. ACOG committee opinion number 419. Use of progesterone to reduce preterm birth. Obstet Gynecol 2008; 112:963-965.
56. ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. The American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002; 78:179-190.
57. Trout SW, Seifer DB. Do women with unexplained recurrent pregnancy loss have higher day 3 serum FSH and estradiol values? Fertil Steril 2000; 74:335-337.
58. Clifford K, Rai R, Regan L. Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod 1997; 12:387-389.
59. Christiansen OB, Andersen AMN, Bosch E, et al. Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril 2005; 83:821-839.
60. Sirrat GM. Recurrent miscarriage. Lancet 1990; 336:673-675.